Companies /Consumer Defensive

Procter & Gamble Company

NYSE: PG Household & Personal Products
$145.84
▲ $0.16 (+0.11%) today
Markets open · 1:38pm ET

PG Coverage

Page 31
8:13am ET
Companies and Brands

Nestle Adds Peanut Allergy Treatment to Its Portfolio

Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.

Paul Ausick